- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-2-mer
- Ligands
- 20 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
NAG.21: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain A: N.122, T.124, V.127
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain A: E.132, N.165
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain A: G.232, N.234
- Chain C: H.519
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain A: N.280, E.281, N.282
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain A: N.603, T.604
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain A: N.616
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain A: N.657
Ligand excluded by PLIPNAG.29: 4 residues within 4Å:- Chain A: N.709, I.1130, G.1131
- Chain B: D.796
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain B: N.122, T.124, V.127, K.129
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain B: N.164, N.165
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain B: N.234
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain B: N.280, E.281, N.282
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain B: F.338, G.339, N.343
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain B: N.603
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain B: N.616
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain B: N.657
Ligand excluded by PLIPNAG.39: 5 residues within 4Å:- Chain B: A.706, E.1072, K.1073, N.1074
- Ligands: NAG.40
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Ligands: NAG.39
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.42: 4 residues within 4Å:- Chain C: N.122, N.125, V.127, F.157
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain C: N.165
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain C: N.234
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain C: E.281, N.282
Ligand excluded by PLIPNAG.46: 4 residues within 4Å:- Chain C: N.331, I.332, Q.580
- Ligands: NAG.47
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Ligands: NAG.46
Ligand excluded by PLIPNAG.48: 1 residues within 4Å:- Chain C: N.603
Ligand excluded by PLIPNAG.49: 1 residues within 4Å:- Chain C: N.616
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain C: H.655, N.657
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yan, R. et al., Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies. Cell Res. (2021)
- Release Date
- 2021-03-10
- Peptides
- Spike glycoprotein: ABC
IG c542_heavy_IGHV3-53_IGHD3-10_IGHJ6,IGH@ protein: DF
IGL c4203_light_IGKV1-9_IGKJ4,IGL c4203_light_IGKV1-9_IGKJ4,Uncharacterized protein: EG - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
JE
KG
N
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-2-mer
- Ligands
- 20 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yan, R. et al., Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies. Cell Res. (2021)
- Release Date
- 2021-03-10
- Peptides
- Spike glycoprotein: ABC
IG c542_heavy_IGHV3-53_IGHD3-10_IGHJ6,IGH@ protein: DF
IGL c4203_light_IGKV1-9_IGKJ4,IGL c4203_light_IGKV1-9_IGKJ4,Uncharacterized protein: EG - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
JE
KG
N